miRNA in Septic Acute Kidney Injury

RecruitingOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
SepsisAcute Kidney InjuryAcute Kidney Injury Due to Sepsis
Interventions
DIAGNOSTIC_TEST

Laboratory examination to determine the presence of sepsis

Standard laboratory biochemical methods will be used to determine sepsis diagnosis accord-ing to SEPSIS 3 (1). Blood samples for obtaining serum/plasma of the patients will be taken on the 1st and 4th day of sepsis diagnosis.

DIAGNOSTIC_TEST

Laboratory examination to determine the presence of sepsis and acute kidney injury

Standard laboratory biochemical methods will be used to determine sepsis diagnosis according to SEPSIS 3 and acute kidney injury according to Guidelines Kidney Disease Improving Global Outcomes (KDIGO) 2012 (2). Blood samples for obtaining serum/plasma of the patients will be taken on the 1st and 4th day of sepsis diagnosis.

DIAGNOSTIC_TEST

Laboratory examination to determine miRNA and biochemical parameters

Laboratory examination will be performed to determine miRNA and biochemical parameters.

Trial Locations (2)

708 52

RECRUITING

University Hospital Ostrava, Ostrava

779 00

RECRUITING

University Hospital Olomouc, Olomouc

All Listed Sponsors
collaborator

University Hospital Olomouc

OTHER

lead

University Hospital Ostrava

OTHER